Dublin, Aug. 10, 2017 (GLOBE NEWSWIRE) -- The "Pharma App Benchmarking 2017" report has been added to Research and Markets' offering.

Since the first report about the app publishing activities of leading Pharma companies was published in 2014, companies have intensified their activities in the digital health market. This report analyses the current status of the app publishing activities of the twelve leading Pharma companies globally. It also analyses newly established channels that Pharma use to partner with 3rd party companies, including accelerators/incubators, investment funds and direct partnerships.

The research provides a detailed perspective on the current status of digital health activities, on a market and company level. It compares the digital health activities that Pharma companies concentrate on, and how successful they are. The report also highlights how app publishing strategies have changed over the last three years.

Key Topics Covered:

1. Scope of the report

2. Management summary

3. The four channels used by Pharma to drive digital innovation with mHealth apps

4. The app publishing activities of top Pharma companies

5. Top 12 Pharma company app portfolio comparison

6. Top 12 Pharma company app profiles and digital health innovation activities

7. How can Pharma further evolve their digital health strategies?

8. Appendix

Companies Mentioned

• Abbott/Abbvie
• AstraZeneca
• Bayer Healthcare
• Bristol-Myers Squibb
• GlaxoSmithKline
• Johnson&Johnson
• Merck
• Merck, Sharpe and Dohme (MSD)
• Novartis
• Pfizer
• Roche
• Sanofi

For more information about this report visit https://www.researchandmarkets.com/research/c28hjv/pharma_app

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716
         Related Topics: Pharmaceuticals

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.